Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Disease × Vincristine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 215 Precursor Cell Lymphoblastic Leukemia-Lymphoma 188 Lymphoma, Large B-Cell, Diffuse 171 Leukemia 102 Burkitt Lymphoma 91 Lymphoma, Non-Hodgkin 88 Lymphoma, Follicular 78 Lymphoma, Mantle-Cell 53 Neuroblastoma 51 Hodgkin Disease 46 Central Nervous System Neoplasms 42 Sarcoma 37 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30 Lymphoma, B-Cell 30 Lymphoma, Large-Cell, Anaplastic 29 Recurrence 28 Lymphoma, T-Cell, Peripheral 28 Lymphoma, Large-Cell, Immunoblastic 27 Rhabdomyosarcoma 25 Neoplasms 25 Multiple Myeloma 24 Medulloblastoma 22 Lymphoma, B-Cell, Marginal Zone 22 Leukemia, Lymphocytic, Chronic, B-Cell 21 Leukemia, Biphenotypic, Acute 21 Brain Neoplasms 20 Sarcoma, Ewing 18 Retinoblastoma 18 Lymphoma, T-Cell 17 HIV Infections 17

Interventions

Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Cyclophosphamide 6 Blood Specimen Collection 6 Prednisone 5 Positron Emission Tomography Computed Tomography 4 Mammography 4 Lenalidomide 4 Colonoscopy 4 pembrolizumab 3 Tomography, X-Ray Computed 3 Surveys and Questionnaires 3 Melphalan 3 Biopsy 3 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3 weifuchun 2 obinutuzumab 2 fluciclovine F-18 2 daratumumab 2 carfilzomib 2 Preoperative Exercise 2 Positron-Emission Tomography 2 Methods 2 Magnetic Resonance Imaging 2 Injections 2 Gemcitabine 2 Exercise 2 Educational Status 2 Doxorubicin 2 Cytarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01659099 2018-03-07

GAINED

The Lymphoma Academic Research Organisation

Phase 3 Terminated

Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡